Headlines about HealthSouth (NYSE:HLS) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. HealthSouth earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 45.923187907704 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the media stories that may have effected Accern’s scoring:

HealthSouth (NYSE:HLS) traded down $0.15 during midday trading on Monday, hitting $49.41. 406,000 shares of the stock were exchanged, compared to its average volume of 887,674. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. HealthSouth has a 1 year low of $38.24 and a 1 year high of $50.41. The company has a market capitalization of $4,870.00, a P/E ratio of 18.03, a PEG ratio of 1.70 and a beta of 0.54.

HealthSouth (NYSE:HLS) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. HealthSouth had a net margin of 6.69% and a return on equity of 22.81%. The firm had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. During the same period last year, the firm earned $0.65 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. equities research analysts expect that HealthSouth will post 2.72 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.02%. HealthSouth’s dividend payout ratio is presently 36.50%.

A number of brokerages have recently commented on HLS. SunTrust Banks set a $58.00 target price on shares of HealthSouth and gave the stock a “buy” rating in a research report on Thursday, December 21st. Zacks Investment Research upgraded shares of HealthSouth from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Royal Bank of Canada reiterated a “buy” rating on shares of HealthSouth in a research note on Wednesday, November 15th. William Blair reiterated an “outperform” rating on shares of HealthSouth in a research note on Tuesday, November 21st. Finally, Piper Jaffray Companies reiterated a “hold” rating and set a $50.00 price objective on shares of HealthSouth in a research note on Sunday, September 17th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $52.44.

In other news, Director Yvonne M. Curl bought 1,000 shares of the stock in a transaction on Wednesday, November 1st. The stock was bought at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the purchase, the director now directly owns 64,144 shares in the company, valued at $2,947,416.80. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/healthsouth-hls-earns-daily-media-impact-rating-of-0-17/1799044.html.

HealthSouth Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Insider Buying and Selling by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with Analyst Ratings Network's FREE daily email newsletter.